{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:21:12Z","timestamp":1789568472397,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ecl.2020.12.002","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T16:51:05Z","timestamp":1610556665000},"page":"97-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Postmenopausal Hyperandrogenism"],"prefix":"10.1016","volume":"50","author":[{"given":"Adnin","family":"Zaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol S.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ecl.2020.12.002_bib1","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1210\/jc.2007-0581","article-title":"Ovarian androgen production in postmenopausal women","volume":"92","author":"Fogle","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.002_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)60609-X","article-title":"Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study","volume":"51","author":"Gershagen","year":"1989","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ecl.2020.12.002_bib3","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/jc.2012-1683","article-title":"Management of postmenopausal virilization","volume":"97","author":"Alpanes","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.12.002_bib5","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2265.2011.04040.x","article-title":"How should postmenopausal androgen excess be evaluated?","volume":"75","author":"Rothman","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.ecl.2020.12.002_bib8","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ecl.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society Clinical Practice Guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2010-0130","article-title":"Hyperandrogenism in women with polycystic ovary syndrome persists after menopause","volume":"96","author":"Markopoulos","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2020.12.002_bib13","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.ecl.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ecl.2020.12.002_bib15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.002_bib16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09513590701807100","article-title":"The investigation and management of severe hyperandrogenism pre- and postmenopause: non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin","volume":"24","author":"Vaikkakara","year":"2008","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.002_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0111","article-title":"Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies","volume":"177","author":"Yance","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5 Pt 2","key":"10.1016\/j.ecl.2020.12.002_bib19","first-page":"893","article-title":"Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary","volume":"99","author":"Krug","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2265.1997.1050916.x","article-title":"Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women","volume":"46","author":"Barth","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib21","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-14-0468","article-title":"Hyperandrogenism after menopause","volume":"172","author":"Markopoulos","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2265.1997.8730882.x","article-title":"Polycystic ovary syndrome, hyperthecosis and the menopause","volume":"46","author":"Rittmaster","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.ecl.2020.12.002_bib23","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1210\/jc.2010-0457","article-title":"Approach to the patient with an adrenal incidentaloma","volume":"95","author":"Nieman","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.002_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-019-0342-y","article-title":"A\u00a0rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10.1016\/j.ecl.2020.12.002_bib25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.surg.2004.06.046","article-title":"Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases","volume":"136","author":"Moreno","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2020.12.002_bib26","unstructured":"Kassi E, Angelousi A, Zografos G, et al. Current issues in the diagnosis and management of adrenocortical carcinomas. [Updated 2016 Mar 6]. In: Feingold KR, Anawalt B, Boyce A, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279009\/."},{"key":"10.1016\/j.ecl.2020.12.002_bib27","first-page":"135","article-title":"Androgens in menopausal women: not only polycystic ovary syndrome","volume":"vol. 53","author":"Ervin","year":"2019"},{"issue":"6","key":"10.1016\/j.ecl.2020.12.002_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0039-6060(03)00410-0","article-title":"Androgen-secreting adrenal tumors","volume":"134","author":"Cordera","year":"2003","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.ecl.2020.12.002_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2012.07.114","article-title":"A\u00a0clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors","volume":"127","author":"Gui","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ecl.2020.12.002_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1477-7819-11-142","article-title":"Ovarian granulosa cell tumors: a retrospective study of 27 cases and a review of the literature","volume":"11","author":"Sekkate","year":"2013","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ecl.2020.12.002_bib32","first-page":"786","article-title":"Androgenic granulosa cell tumors of the ovary. A clinicopathologic analysis of 17 cases and review of the literature","volume":"108","author":"Nakashima","year":"1984","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.002_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0378-5122(88)90098-9","article-title":"Hormonal activity of epithelial ovarian tumours in post-menopausal women","volume":"9","author":"Heinonen","year":"1988","journal-title":"Maturitas"},{"issue":"10","key":"10.1016\/j.ecl.2020.12.002_bib34","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1210\/jc.2014-2260","article-title":"Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline","volume":"99","author":"Wierman","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.002_bib35","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1210\/jc.2016-1271","article-title":"Compounded bioidentical hormones in endocrinology practice: an Endocrine Society Scientific Statement","volume":"101","author":"Santoro","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.12.002_bib36","series-title":"Endocrine News","first-page":"22","article-title":"Targeting patients with pellets: a look at bioidentical hormones","author":"Seaborg","year":"2019"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.002_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2000.01117.x","article-title":"How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?","volume":"53","author":"Kaltsas","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.002_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/0974-7753.188998","article-title":"Hyperprolactinemia and hirsutism in patients without polycystic ovary syndrome","volume":"8","author":"Tirgar-Tabari","year":"2016","journal-title":"Int J Trichology"},{"issue":"7","key":"10.1016\/j.ecl.2020.12.002_bib39","first-page":"678","article-title":"Androgen suppression and clinical improvement with dopamine agonists in hyperandrogenic-hyperprolactinemic women","volume":"46","author":"Hagag","year":"2001","journal-title":"J\u00a0Reprod Med"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.002_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12020-014-0308-9","article-title":"The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons","volume":"48","author":"Faje","year":"2015","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.ecl.2020.12.002_bib41","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jcem.84.8.5858","article-title":"Menstrual irregularity in women with acromegaly","volume":"84","author":"Kaltsas","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2020.12.002_bib42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2265.2007.02987.x","article-title":"Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly","volume":"67","author":"Kaltsas","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.002_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.002_bib44","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1530\/EJE-17-0776","article-title":"Management of endocrine disease hyperandrogenic states in women: pitfalls in laboratory diagnosis","volume":"178","author":"Pugeat","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2020.12.002_bib45","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2020.12.002_bib46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-0542","article-title":"Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism","volume":"165","author":"Sarfati","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.002_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cen.13492","article-title":"Clinical case seminar: postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis","volume":"88","author":"Mamoojee","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2020.12.002_bib48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1994.tb01820.x","article-title":"Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours","volume":"41","author":"Pascale","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.002_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00001622-200301000-00013","article-title":"Adrenal incidentaloma","volume":"15","author":"Thompson","year":"2003","journal-title":"Curr Opin Oncol"},{"issue":"11","key":"10.1016\/j.ecl.2020.12.002_bib50","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an Endocrine Society Clinical Practice Guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.002_bib51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2265.2003.01792.x","article-title":"Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?","volume":"59","author":"Kaltsas","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.ecl.2020.12.002_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11892-017-0956-2","article-title":"Cardiometabolic risk in PCOS: more than a reproductive disorder","volume":"17","author":"Torchen","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ecl.2020.12.002_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.002_bib54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11154-018-9454-3","article-title":"Cardiovascular health in transgender people","volume":"19","author":"Irwig","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.ecl.2020.12.002_bib55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1210\/js.2018-00405","article-title":"Persistent poor metabolic profile in postmenopausal women with ovarian hyperandrogenism after testosterone level normalization","volume":"3","author":"Rocha","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.002_bib56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijgo.2007.08.017","article-title":"Insulin resistance causing severe postmenopausal hyperandrogenism","volume":"100","author":"Al-Ozairi","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ecl.2020.12.002_bib57","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/jc.2010-1991","article-title":"Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin","volume":"96","author":"Vollaard","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2020.12.002_bib58","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/GCO.0b013e32833e1264","article-title":"Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update","volume":"22","author":"Katsiki","year":"2010","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:46:43Z","timestamp":1760176003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852920300906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0889852920300906"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2020.12.002","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postmenopausal Hyperandrogenism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}